Sonnet Biotherapeutics Holdings Inc logo

Sonnet Biotherapeutics Holdings Inc share price today

(SONN)

Sonnet Biotherapeutics Holdings Inc share price is $2.1 & ₹177.85 as on 7 Dec 2024, 2.30 'hrs' IST

$2.1

0.39

(22.81%)

Market is closed - opens 8 PM, 09 Dec 2024

View live Sonnet Biotherapeutics Holdings Inc share price in Dollar and Rupees. Guide to invest in Sonnet Biotherapeutics Holdings Inc from India. Also see the sentimental analysis on Indian investors investing in Sonnet Biotherapeutics Holdings Inc. Get details on the Indian mutual funds that are investing in Sonnet Biotherapeutics Holdings Inc. Get Analyst recommendations and forecasts along with all the Sonnet Biotherapeutics Holdings Inc's financials.

Sonnet Biotherapeutics Holdings Inc share price movements

  • $1.74
    $2.22

    Day's Volatility :21.62%

  • $1.66
    $18.72

    52 Weeks Volatility :91.13%

Sonnet Biotherapeutics Holdings Inc Returns

PeriodSonnet Biotherapeutics Holdings IncIndex (Russel 2000)
3 Months
-75.34%
0.0%
6 Months
-89.15%
0.0%
1 Year
-86.3%
0.0%
3 Years
-99.87%
-21.5%

Sonnet Biotherapeutics Holdings Inc Key Statistics

in dollars & INR

Previous Close
$1.71
Open
$1.74
Today's High
$2.22
Today's Low
$1.74
Market Capitalization
$1.4M
Today's Volume
$229.0K
52 Week High
$18.7192
52 Week Low
$1.66
Revenue TTM
$55.9K
EBITDA
$-12.3M
Earnings Per Share (EPS)
$-0.96
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-264.57%

How to invest in Sonnet Biotherapeutics Holdings Inc from India?

It is very easy for Indian residents to invest directly in Sonnet Biotherapeutics Holdings Inc from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Sonnet Biotherapeutics Holdings Inc stock in both rupees (INR) and dollars (USD). Search for Sonnet Biotherapeutics Holdings Inc or SONN on INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Sonnet Biotherapeutics Holdings Inc or Rupee/ Dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Sonnet Biotherapeutics Holdings Inc shares which would translate to 0.403 fractional shares of Sonnet Biotherapeutics Holdings Inc as of today. Learn more about fractional investing here.

Indians via INDmoney can now also, easily transfer and add their money to the US stocks account via INDmoney App. Click here for step by step process for the same

Indian investors sentiment towards Sonnet Biotherapeutics Holdings Inc

448.0%

Period: Sep 7, 2024 to Dec 6, 2024. Change in 30 Days versus previous period

Investment in Sonnet Biotherapeutics Holdings Inc from India has grown in the last 30 days as on Dec 7, 2024. 448.0% more purchase transactions for Sonnet Biotherapeutics Holdings Inc in the last 30 days versus the previous period.

965%

Period: Sep 7, 2024 to Dec 6, 2024. Change in 30 Days versus previous period

Search volume for Sonnet Biotherapeutics Holdings Inc on INDmoney from India has grown in the last 30 days as on Dec 7, 2024. 965% more investors are searching Sonnet Biotherapeutics Holdings Inc in the last 30 days versus the previous period.

Global Institutional Holdings in Sonnet Biotherapeutics Holdings Inc

  • Sabby Management LLC

    3.56%

  • Virtu Financial LLC

    0.49%

  • BlackRock Inc

    0.01%

  • Tower Research Capital LLC

    0.01%

Analyst Recommendation on Sonnet Biotherapeutics Holdings Inc

Buy

    90%Buy

    10%Hold

    0%Sell

Based on 10 Wall street analysts offering stock ratings for Sonnet Biotherapeutics Holdings Inc(by analysts ranked 0 to 5 stars)

Based on 10 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
9
9
9
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Sonnet Biotherapeutics Holdings Inc

What analysts predicted

Upside of 11328.57%

Current:

$2.10

Target:

$240.00

Insights on Sonnet Biotherapeutics Holdings Inc

  • Decreasing Revenue

    Revenue is down for the last 2 quarters, 37.25K → 18.62K (in $), with an average decrease of 50.0% per quarter
  • Decreasing Net Profit

    Netprofit is down for the last 2 quarters, 365.42K → -3.50M (in $), with an average decrease of 1059.3% per quarter
  • Vs ALNY

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 42.1% return, outperforming this stock by 128.5%
  • Vs VRTX

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 39.7% return, outperforming this stock by 139.6%

Sonnet Biotherapeutics Holdings Inc Technicals Summary

Sell

Neutral

Buy

Sonnet Biotherapeutics Holdings Inc is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Sonnet Biotherapeutics Holdings Inc Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Sonnet Biotherapeutics Holdings Inc
-53.66%
-89.15%
-86.3%
-99.87%
-99.99%
Regeneron Pharmaceuticals, Inc.
-6.86%
-23.34%
-8.6%
17.41%
110.02%
Biontech Se
10.16%
21.29%
14.9%
-59.29%
309.79%
Alnylam Pharmaceuticals, Inc.
-7.5%
64.08%
48.09%
42.33%
108.61%
Vertex Pharmaceuticals Incorporated
-8.46%
-4.83%
31.35%
122.6%
109.65%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Sonnet Biotherapeutics Holdings Inc
0.25
NA
NA
-12.88
-2.65
-0.97
NA
4.01
Regeneron Pharmaceuticals, Inc.
18.56
18.56
1.12
44.92
0.17
0.07
NA
272.04
Biontech Se
160.8
NA
0.04
-3.06
-0.02
-0.01
NA
79.73
Alnylam Pharmaceuticals, Inc.
NA
NA
-0.49
-0.19
-15.01
-0.03
NA
0.25
Vertex Pharmaceuticals Incorporated
32.84
NA
1.21
0.54
-0.03
0.12
NA
60.65
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Sonnet Biotherapeutics Holdings Inc
Buy
$1.4M
-99.99%
0.25
0.0%
Regeneron Pharmaceuticals, Inc.
Buy
$82.9B
110.02%
18.56
33.61%
Biontech Se
Buy
$28.5B
309.79%
160.8
-15.36%
Alnylam Pharmaceuticals, Inc.
Buy
$32.7B
108.61%
NA
-15.86%
Vertex Pharmaceuticals Incorporated
Buy
$118.4B
109.65%
32.84
-4.51%

About Sonnet Biotherapeutics Holdings Inc

sonnet biotherapeutics is an early stage company developing a pipeline of bifunctional therapies that attack immune-modulating targets to control cancer cells. sonnet biotherapeutics is utilizing a platform approach to develop a library of cancer-fighting immunotherapies. sonnet is based in cranbury, new jersey. sonnet mission: sonnet biotherapeutics is a platform enabled proof-of-concept engine created to generate immuno-oncology candidates and develop them into phase ii assets. we are leveraging a unique ip driven platform: ● single chain platform with pk enhancement ● selectively targeting tumors and their micro-environment ● validated targets only ● dual targeting can create synergies
Organization
Sonnet Biotherapeutics Holdings Inc
Employees
12
CEO
Dr. Pankaj Mohan Ph.D.
Industry
Consumer Services

Management People of Sonnet Biotherapeutics Holdings Inc

NameTitle
Dr. Pankaj Mohan Ph.D.
Founder, Chairman, CEO & President
Dr. John K. Cini Ph.D.
Chief Scientific Officer & Co-Founder
Mr. Jay Cross
Chief Financial Officer
Mr. Donald J. Griffith CPA, CPA
Financial Controller & Director
Dr. Gael Hedou Ph.D.
Chief Operating Officer
Ms. Susan Dexter
Chief Technical Officer
Dr. Richard T. Kenney FACP, M.D.
Chief Medical Officer
Mr. Manuel Dafonseca
Head of Clinical Operations
Dr. Stephen J. McAndrew Ph.D.
Senior Vice President of Business Development

Important FAQs about investing in Sonnet Biotherapeutics Holdings Inc from India :

What is Sonnet Biotherapeutics Holdings Inc share price today?

Sonnet Biotherapeutics Holdings Inc (SONN) share price today is $2.10.

Can Indians buy Sonnet Biotherapeutics Holdings Inc shares?

Yes, Indians can invest in the Sonnet Biotherapeutics Holdings Inc (SONN) from India.

With INDmoney, you can buy Sonnet Biotherapeutics Holdings Inc at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Sonnet Biotherapeutics Holdings Inc at zero transaction cost.

How can I buy Sonnet Biotherapeutics Holdings Inc shares from India?

It is very easy to buy Sonnet Biotherapeutics Holdings Inc from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Sonnet Biotherapeutics Holdings Inc be purchased?

Yes, you can buy fractional shares of Sonnet Biotherapeutics Holdings Inc with INDmoney app.

What are the documents required to start investing in Sonnet Biotherapeutics Holdings Inc stocks?

To start investing in Sonnet Biotherapeutics Holdings Inc, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Sonnet Biotherapeutics Holdings Inc

Today’s highest price of Sonnet Biotherapeutics Holdings Inc (SONN) is $2.22.

Today’s lowest price of Sonnet Biotherapeutics Holdings Inc (SONN) is $1.74.

What is today's market capitalisation of Sonnet Biotherapeutics Holdings Inc

Today's market capitalisation of Sonnet Biotherapeutics Holdings Inc SONN is 1.4M

What is the 52 Week High and Low Range of Sonnet Biotherapeutics Holdings Inc

  • 52 Week High

    $18.72

  • 52 Week Low

    $1.66

How much percentage Sonnet Biotherapeutics Holdings Inc is down from its 52 Week High?

Sonnet Biotherapeutics Holdings Inc (SONN) share price is $2.10. It is down by 99% from its 52 Week High price of $18.72.

How much percentage Sonnet Biotherapeutics Holdings Inc is up from its 52 Week low?

Sonnet Biotherapeutics Holdings Inc (SONN) share price is $2.10. It is up by 1% from its 52 Week Low price of $1.66.

What are the historical returns of Sonnet Biotherapeutics Holdings Inc?

  • 1 Month Returns

    -53.66%

  • 3 Months Returns

    -89.15%

  • 1 Year Returns

    -86.3%

  • 5 Years Returns

    -99.99%

Who is the Chief Executive Officer (CEO) of Sonnet Biotherapeutics Holdings Inc

Dr. Pankaj Mohan Ph.D. is the current Chief Executive Officer (CEO) of Sonnet Biotherapeutics Holdings Inc.